证券记录 · 已归档季度
REPL
Replimune Group, Inc. · Healthcare · Biotechnology
16被追踪持有人
0Δ持有人
29.86M持有股份
$277.39M报告持仓市值
+0新建仓位
−0清仓
动量输入(同类管理人): 持有人广度 0.0% · 股份流向 -1.7% · 净新建仓位 0.0% · 公式
所有持股数据:仅限已追踪的 13F 管理人,普通股持仓,报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 75 | +2 | 45.55M | $503.98M | +13 | −11 |
| Q1 2026 | 75 | +4 | 41.32M | $315.89M | +10 | −6 |
| Q4 2025 | 71 | +3 | 45.45M | $441.76M | +3 | n/a |
| Q3 2025 | 15 | -4 | 32.26M | $135.16M | n/a | −4 |
| Q2 2025 | 16 | 0 | 29.86M | $277.39M | n/a | n/a |
| Q1 2025 | 13 | 0 | 20.78M | $202.64M | n/a | n/a |
| Q4 2024 | 13 | +1 | 19.63M | $237.78M | +2 | −1 |
| Q3 2024 | 11 | +1 | 14.48M | $158.71M | +1 | n/a |
| Q2 2024 | 10 | n/a | 16.01M | $144.07M | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 10.82M | -0.3% | $100.51M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 2 | BlackRock ✦ (被动) | 5.73M | n/a | $53.24M | 0.0% | n/c | 1 | SEC ↗ ×12 |
| 3 | The Vanguard Group ✦ (被动) | 3.47M | n/a | $32.23M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 4 | State Street Global Advisors ✦ (被动) | 2.45M | +2.3% | $22.79M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Marshall Wace ✦ | 1.87M | -25.0% | $17.34M | 0.0% | ▼ Trim | 3 | SEC ↗ ×3 |
| 6 | Geode Capital Management ✦ (被动) | 1.62M | -2.9% | $15.09M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 7 | Wellington Management ✦ | 944.51K | +0.9% | $8.77M | 0.0% | ▲ Add | 5 | SEC ↗ ×5 |
| 8 | Millennium Management ✦ | 794.05K | -35.1% | $7.38M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 9 | Point72 Asset Management ✦ | 712.54K | +642.4% | $6.62M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 506.60K | -36.4% | $4.71M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 11 | Fidelity (FMR) ✦ | 391.66K | n/a | $3.64M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 12 | Citadel Advisors ✦ | 277.47K | +1119.4% | $2.58M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 153.09K | -2.0% | $1.42M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 14 | Fisher Asset Management ✦ | 81.95K | 0.0% | $761,306 | 0.0% | Held | 5 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 22.42K | -49.5% | $208,291 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 12.21K | -7.8% | $113,450 | 0.0% | ▼ Trim | 4 | SEC ↗ ×3 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例,即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构(SEC结构化数据, Q1 2026): 178 持有人, 80.31M 股份, $547.04M 已申报. 这是与上方被追踪全域数据不同的较早期间,两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券:基于共同持有计数,而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 17
Hill Emily Luisa
Officer · 9.26K 股 · $132,176
Aug 10
Hill Emily Luisa
Officer · 11.45K 股 · $148,481
Aug 10
Patel Sushil
Officer, Director · 39.34K 股 · $510,253
Aug 10
Schwendenman Andrew
Officer · 7.63K 股 · $98,987
Aug 10
Xynos Konstantinos
Officer · 11.45K 股 · $148,468
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 14
SC 13G/A: Ridgeback Capital Investments L.P.
Aug 11
SC 13D/A: BAKER BROS. ADVISORS LP
11.8% 占股份类别 · 查看 SEC 原始申报文件 ↗
Aug 10
SC 13G: GOLDMAN SACHS GROUP INC
Aug 07
SC 13G: STATE STREET CORP
Aug 06
SC 13G/A: MONTANOVA CAPITAL, LLC
May 21
SC 13G: Ridgeback Capital Investments L.P.
数据来源: 持股数据来源于已解析的13F普通股持仓(被追踪范围,变动对比集);内部人行为来自Form 3/4/5;重大持股来自Schedule 13D/13G;所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据